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Short title ETHICAL: Ethnic Disparities In COVID-19 Admissions  in east London 
Methodology 
Observational cohort study of treatment and outcomes in 
Black, Asian and Minority Ethnic (BAME) and non-BAME 
patients with a confirmed diagnosis of COVID-19 
(positive SARS-CoV-2 swab) admitted to Barts Health 
NHS Trust 
Objectives / aims 
• Assess whether there is a difference in outcomes 
(ITU admission/Advanced Respiratory Support/ 
Death) between different ethnic backgrounds of 
patients with confirmed diagnosis of COVID-19 
(positive SARS-CoV-2 swab) admitted to Barts 
Health 
• To analyse differences in age, sex, comorbidity and 
measure of economic deprivation in COVID-19 
positive patients of Black, Asian and other ethnicities, 
compared to COVID-19 positive patients of non-
BAME ethnicity admitted to hospitals in Barts Health 
NHS Trust and to understand their association with 
adverse outcomes 
Number of 
participants 
Around 2000 
Inclusion and 
exclusion criteria 
Inclusion Criteria: 
• Confirmed COVID-19 by positive SARS-CoV-2 PCR 
• Inpatient admission at Royal London Hospital, 
Newham General Hospital, Whipps Cross Hospital, St 
Bartholomew’s Hospital (+/- Nightingale Hospital) 
Exclusion Criteria: 
• Unknown or undisclosed ethnicity 
Statistical 
methodology and 
analysis (if 
applicable) 
• Prospectively Defined Observational study 
• Descriptive and comparative analyses of 
demographics, clinical characteristics and clinical 
outcomes between patients of different ethnicities 
using univariate and multivariate analysis. 
Study duration 18 months (for full follow up and final analysis)  
 
1. Introduction 
 
1.1. Background 
 
On 31st December 2019, Chinese authorities notified the World Health Organisation (WHO) 
of an outbreak of pneumonia in Wuhan City, which was later classified as a new disease; 
coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2)1. It was declared a pandemic by the WHO on March 11th 20202 
and in the United Kingdom (UK) the disease has significantly impacted all aspects of the 
national health and social care economy3. 
 
COVID-19 is a heterogeneous disease, with differential impact on individuals. The symptoms 
vary widely, from asymptomatic disease to pneumonia and life-threatening complications. 
There is a clear imperative to identify patient subpopulations with poorer prognoses to 
optimise their management. The presence of co-morbidity has been associated with poorer 
clinical outcomes4,5; with circulatory diseases (including hypertension, coronary heart disease 
and heart failure) and diabetes being key factors4,5. Other factors such as older age, male sex, 
obesity and smoking are also associated with worse outcomes6,7. 
 
Preliminary analyses of the UK Intensive care national audit and research centre (ICNARC) 
report on COVID-19 in critical care have signalled ethnicity as a predictor of poorer clinical 
outcomes8. 34.5% of patients requiring ITU admission were of Black, Asian, Mixed or Other 
ethnicity; this is disproportionate to Black, Asian and Minority Ethnic (BAME) only making up 
13% of the UK population9. This over-representation extends to the number of NHS frontline 
staff known to have died in the pandemic so far; with 68% being of a BAME background10. 
Ethnicity has also been shown to be a pivotal driver of the US epidemic with predominantly 
black counties experiencing death rates 3-fold higher than predominantly white counties11. 
This emerging disparity warrants further investigation. To date, no UK hospital COVID-19 
mortality data, stratified by ethnicity, has been publicly presented. 
 
“Race" and "ethnicity" are complex and distinct parameters that are often used 
interchangeably. Race is a historical social construct. It refers to categories of human beings 
based on shared physical traits but has no genetic basis12. Ethnicity denotes groups that share 
a common identity-based ancestry, language, or culture13. It is currently the best marker we 
have for defining population subgroups as it can serve as a proxy for shared risks for people 
with similar, social, biological and cultural characteristics. Ethnicity is self-reported by patients 
at registration in clinical settings and coded based on the UK Census categorisation 
hierarchies13. 
 
The 2020 Marmot review reported that the last decade has been marked by deteriorating 
health and widening health inequalities14. Health is influenced by a wide range of factors, 
including biological determinants (age, gender, hereditary factors), and wider social 
determinants such as education, social position, income, poverty, local environment, and 
experiences of racism and institutional racism. Each factor shapes health individually and by 
intersecting with other factors to have a synergistic impact. 
 
The signal of ethnic inequality being highlighted in COVID-19 is not new. Health inequalities 
within and between ethnic minority groups are known to be transmitted across generations13. 
Ethnic minorities tend to have poorer health than majority ethnic groups. This has been clearly 
demonstrated in a range of conditions such as cardiovascular disease, diabetes, stroke and 
hypertension13. The relationship between ethnicity and health is complex, interacting in ways 
we are only beginning to understand. These inequalities have led to unjust and preventable 
inequalities in health13,15. In the context of COVID-19, a number of potential causes have been 
postulated. 
 
BAME people are twice as likely to be living in poverty and are more likely to be employed in 
a key worker role with an increased risk of COVID-19 acquisition or experience housing 
deprivation16. This exposure is compounded by a background increased risk of heart disease 
and diabetes; both shown to be risk factors of severe COVID-19 infection. Public concern has 
been raised about BAME patients presenting late to hospital with advanced symptoms due to 
language barriers or fear of reprisal for employers, being unable to advocate for adequate 
personal protective equipment in certain keyworker roles17 and receiving different approaches 
to management and escalation of care. Atchison et al have emphasised that those most 
economically disadvantaged in society are less able to comply with certain governmental 
advice18. Although willingness to self-isolate was high overall in their cross-sectional survey, 
those from more disadvantaged backgrounds were less likely to be able to work from home 
or self-isolate if needed, suggesting the existence of structural barriers to adopting preventive 
behaviours in these groups. 
 
1.1. Rationale 
 
The Barts Health footprint encompasses diverse populations; some challenged by some of 
the worst socio-economic deprivation and highest neighbourhood Index of Multiple 
Deprivation (IMD) scores. As such there is local incentive to identify and swiftly intervene as 
necessary. Inequalities will not be eliminated overnight. However, understanding where they 
emerge is a crucial first step towards tackling them. Failing to respond to the emerging 
disparities in this pandemic significantly risks not only reinforcing pre-existing structures of 
racial inequality in society, but further embedding them.  
 
Our study is responding to national call to generate robust scientific data to inform the debate 
of the impact of COVID-19 on BAME communities. This will be the first UK study to assess 
whether there is a difference in hospital outcomes in patients of different ethnicities diagnosed 
with COVID-19. It will test the hypothesis that patients of Black, Asian and other ethnicities 
have poorer in-patient outcomes; in terms of need for ITU admission and mortality. Data 
generated has the potential to influence and shape relevant policy and practice to improve 
health outcomes in BAME communities in this devastating pandemic. 
 
 
  
 
 
2. Study objectives 
 
2.1. Primary objective 
 
This study aims to assess whether there is an age-adjusted difference in outcomes in different 
ethnicities of patients with confirmed COVID 19 admitted to Barts Health. 
 
The study will test the hypothesis that there is an association between health outcomes; in 
terms of need for ITU admission and mortality; and ethnicity in COVID-19 positive patients 
admitted to Barts Health; with patients of Black, Asian and other ethnicities having poorer 
outcomes as compared to patients of white ethnicity. 
 
2.2. Secondary objective 
 
We will examine the strength and nature of relationship between ethnic background and 
outcome in multivariable age and co-morbidity adjusted multivariable survival analysis. 
 
We hypothesise that BAME background patients may be disproportionately younger, have 
greater baseline co-morbidity and have greater economic deprivation than non-BAME 
counterparts and we will document these differences and explore their effects on outcome in 
the analysis. 
 
2.3. Primary endpoint 
 
The primary endpoint will be 30-day Mortality from time of first hospital admission with 
COVID 19 diagnosis. 
 
2.4. Secondary endpoints 
 
The secondary endpoints will be: 
• ITU admission 
• Mortality (in hospital) 
o Death in critical care 
o Death on ward  
• Discharged from hospital alive 
o Discharge destination 
• Length of stay in hospital 
• Length of stay in ITU 
• Organ support received at any time 
o Yes  
o No 
• Duration of organ support 
• Respiratory support  
o Yes 
§ Basic 
§ Advanced  
o No 
• Acute kidney injury 
• Need for Renal support 
• HLH score >169 
• Highest HLH 
 
3. Study population 
 
3.1. Inclusion criteria 
 
• Confirmed SARS COV19 diagnosis by PCR  
• Inpatient admission at Royal London Hospital, Newham General Hospital, Whipps Cross 
Hospital, St Bartholomew’s Hospital (+/- Nightingale Hospital) 
 
3.2. Exclusion criteria 
 
• Unknown or undisclosed ethnicity status 
 
 
4. Study design 
 
This is a prospectively defined observational cohort study utilising data from the Barts Health 
Electronic Patient Record (EPR) system. It will involve analysis of data of patients admitted to 
hospitals within Barts Health hospitals. 
 
Data analysis will include, but not limited to: 
• A comparison of clinical characteristics between inpatients with confirmed COVID-19 of 
different ethnicities. 
• An assessment of clinical outcomes of inpatients with confirmed COVID-19. 
• An assessment of ethnicity as a predictor of outcome using univariate and multivariate 
analysis. This will include adjustment for potential confounders such as co-morbidity and 
postcode of residence/Index of Multiple Deprivation (IMD). 
• An assessment of other potential predictors of outcome using univariate and multivariate 
analysis.  
 
 
5. Study procedures 
 
Consent 
This study involves the aggregated analysis of an anonymised dataset collated by members 
of the direct care team and should not require REC review or consent. See ethics section 
below. 
 
Data collection 
Hospital Cerner Millennium Data Warehouse records will then be used to obtain clinical, 
demographic and blood results by members of the clinical team participating in this study.  
 
The existing ICNARC (Intensive Care National Audit & Research Centre) hospital database 
will be screened for ICU admissions fitting the inclusion criteria. National and local ICNARC 
data analysis are Care Quality Commission National Information Governance Committee 
approved processes. 
 
No patient notes will be required or examined.  This data will be recorded in a Microsoft Excel 
Database maintained under password protection on the secure Trust internal network. After 
results for each patient have been collated by a member of the direct clinical care team. Once 
collation of the database is complete an anonymised database (lacking all patient identifiable 
details - (name, hospital number, date of birth and admission no.) will be analysed by the 
investigators. For analysis see statistical details below. 
 
 
 
 
6. Statistical considerations 
 
The Chief Investigator takes responsibility for the statistics and statistical oversight for this 
study.  
 
6.1. Sample size  
 
The cohort to be analysed in this study comprises patients admitted during the study period. 
This includes all inpatients with COVID-19 admitted to Barts Health NHS Trust between 1st 
January 2020 and 31st July 2020. 
 
Due to the urgent need for data examining outcome in this healthcare emergency an Initial 
analysis based on admissions to 27th April 2020 will be performed 
 
This will be a retrospective review of routinely collected data and we anticipate that over 
2000 patients will meet our inclusion criteria, but the final sample size will be dictated by the 
data available.  
 
 
6.2. Method of analysis  
 
Software 
Statistical analyses will be performed using R: A language and environment for statistical 
computing (R Core Team (2020). R Foundation for Statistical Computing, Vienna, Austria. 
http://www.R-project.org/).  
 
Statistical Analysis  
 
Definitions 
 
Ethnicity 
The ethnic categories to be used will be the 16+1 ethnic data categories defined in the 2001 
census which form national mandatory standard for the collection and analysis of ethnicity in 
the NHS data dictionary. 
 
These are: 
 
White 
A British 
B Irish 
C Any other White background 
  
Mixed 
D White and Black Caribbean 
E White and Black African 
F White and Asian 
G Any other mixed background 
  
Asian or Asian British 
H Indian 
J Pakistani 
K Bangladeshi 
L Any other Asian background 
  
Black or Black British 
M Caribbean 
N African 
P Any other Black background 
  
Other Ethnic Groups 
R Chinese 
S Any other ethnic group 
Z Not stated (excluded from this analysis) 
 
In order to preserve statistical power to detect differences between groups primary analysis 
will be performed between ethnicity as defined by the 5-high level groups White, Mixed, Asian 
or Asian British, Black or Black British and Other. 
 
Death will be defined by the presence of a date of death or discharge destination “patient died” 
in hospital electronic records (these are synchronised with NHS spine to capture out of hospital 
deaths). 
 
Secondary haemophagocytic lymphohistiocytosis 
Secondary haemophagocytic lymphohistiocytosis (sHLH) risk score will be calculated from 
peak values using the following table (see Mehta P, et al. COVID-19: consider cytokine storm 
syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034.) 
 
 
 
Hospital Frailty risk score 
Hospital Frailty risk score will be calculated from prior ICD-10 coding of hospital attendances 
using mapped described in Lancet 2018; 391: 1775–82. 
 
Acute Kidney injury 
Will be defined using the KDIGO 2012 creatinine criteria. Baseline Creatinine will be the 
median value in the 7 to 365 days before hospitalisation.  Absent baseline creatinine will be 
imputed based on and eGFR of 75ml/min/1.72m2 or the admission value whichever is lower. 
 
Comorbidity 
Charlson Comorbidity Index and co-morbidities will be calculated from prior ICD-10 codes 
based on the mapping of Quan H et al. Coding algorithms for defining comorbidities in ICD-9-
CM and ICD-10 administrative data. Med Care. 2005 Nov;43(11):1130-9. 
Diagnosis of Hypertension will be based on mapping ICD-10 codes to the Elixhauser 
comorbidity index.  Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for 
use with administrative data. Med Care 1998;36:8-27 
 
End stage Renal disease will be defined based on prior ICD-10 coding following: Crellin E, et 
al (2017). Clinical Code List - ICD-10 - End-Stage Renal Disease. [Data Collection]. London 
School of Hygiene & Tropical Medicine. https://doi.org/10.17037/DATA.241. 
 
History of tobacco use will be defined by presence of the ICD codes F17.1-F17.2, Z72.0, 
Z87.8, Z71.6 and T65.2. 
 
Index of Multiple Deprivation 
Index of Multiple Deprivation will be defined from patient home address postcode using UK 
government statistics https://www.gov.uk/government/statistics/english-indices-of-
deprivation-2019.  IMD will be presented as raw score and quintiles within the greater London 
area 
 
Analysis 
Clinical outcomes for the whole cohort will be analysed and also stratified by ethnicity. 
Univariate and multivariate analyses will subsequently be used to investigate predictors of 
outcome for each ethnicity. 
 
All continuous data will be expressed as median and interquartile range (IQRs) and categorical 
data as proportion. For continuous data, we will compare the mean difference between groups 
by ANOVA or Kruskal-Wallis test. For dichotomous data, we will use Pearson Chi-square test 
or Fisher exact test (if expected number less than 5).  The log-rank and Wilcoxon test will be 
used for survival time comparisons between groups.  
 
Sample Table 1 
 
 Black Asian Mixed Other  White P value 
Age        
Sex       
IMD       
BMI       
Smoking       
Hospital admission 
CCI       
Hospital Frailty Risk Score       
IMD       
DM       
DMc       
HT       
IHD       
COPD       
CKD       
Baseline eGFR       
ESRD       
AKI       
ICU?       
Basic Resp       
Advanced Resp       
Circulatory       
Renal       
Creatinine       
CRP       
D-dimer       
Peak HLH score       
Peak HLH >169?       
 
Primary and Secondary Endpoint Analysis 
 
Primary endpoint will be 30-day mortality between ethic groupings adjusted for patient age 
and sex. 
 
Mortality comparison will be analysed Cox-proportional Hazard analysis censored at 30 days 
or time of maximal follow-up.  
 
Age and sex adjusted incidence of secondary endpoints will be assessed using logistic 
regression on Cox hazard models as appropriate. 
 
Multi-variable analyses 
 
If available, the following variables will be collected and considered in multi-variable analysis 
for primary and secondary endpoints using logistic regression on Cox hazard models as 
appropriate 
 
• Age 
• Gender 
• BMI 
• Smoking status 
• Clinical frailty Scale at admission if recorded 
• Co-morbidities based on ICD-10 coding for current and previous admission based on 
established mapped to Charlson Co-morbidty index and Elixhauser Index 
• Specific comorbidities for consideration 
o Hypertension with and without complications 
o Diabetes with and without complications 
• Prior end stage renal disease 
• Index of Multiple deprivation 
 
Sensitivity analyses 
 
Multiple imputation will be undertaken to account for missing data for prespecified variables 
included in the above models. Results from imputed analysis will be presented only for the 
primary exposure variable of ethnicity. Multi-variable analysis will be repeated using aggregate 
measures of frailty in place of specific co-morbidities listed above. Survival will also be 
assessed using 90-day mortality.  
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